Symptoms underlying unawareness of memory impairment in patients with mild Alzheimer's disease

Journal of Geriatric Psychiatry and Neurology

Volumn 19, Issue 1, 2006, Pages 3-12

  Kazui, Hiroaki ^a,b,i   Hirono, Nobutsugu ^b,c   Hashimoto, Mamoru ^b,d   Nakano, Yoko ^b,e   Matsumoto, Keiji ^b,f   Takatsuki, Yohoko ^b,g   Mori, Etsuro ^b,h   Ikejiri, Yoshitaka ^a   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Hyogo Brain and Heart Center   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d Sawa Hospital   (Japan)

^e UNIVERSITY OF FUKUI   (Japan)

^f HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^g KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Cognitive impairment; Delusion; Memory impairment; Psychiatric symptom; Unawareness

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN FUNCTION; CAREGIVER; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; DEMOGRAPHY; DEPTH PERCEPTION; DISEASE SEVERITY; EVERYDAY MEMORY CHECKLIST; FEMALE; FRONTAL LOBE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; MEMORY DISORDER; MENTAL DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SELF CONCEPT; SYMPTOM;

AFFECTIVE SYMPTOMS; AGE FACTORS; AGED; ALZHEIMER DISEASE; AWARENESS; COMORBIDITY; DELUSIONS; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MEMORY, SHORT-TERM; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SICK ROLE; STATISTICS;

EID: 33744495099     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988705277543     Document Type: Article

References (54)

1. Feher EP, Mahurin RK, Inbody SB. Anosognosia in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4:136-146.
2. Wagner MT, Spangenberg KB, Bachman DL, O'Connell P. Unawareness of cognitive deficit in Alzheimer's disease and related dementias. Alzheimer Dis Assoc Disord. 1997;11:125-131.
3. Seltzer B, Vasterling JJ, Yoder JA, Thompson KA. Awareness of deficit in Alzheimer's disease: relation to caregiver burden. Gerontologist. 1997;37:20-24.
4. Mangone CA, Hier DB, Gorelick PB, et al. Impaired insight in Alzheimer's disease. J Geriatr Psychiatry Neurol. 1991;4:189-193.
5. Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R. Two domains of ansognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;61:485-490.
6. Starkstein SE, Vazquez S, Migliorelli R, Teson A, Sabe L, Leiguarda R. A single-photon emission computed tomographic study of anosognosia in Alzheimer's disease. Arch Neurol. 1995;52:415-420.
7. Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer's disease. Alzheimer Dis Assoc Disord. 1996;10:68-76.
8. Michon A, Deweer B, Pillon B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994;57:805-809.
9. Lopez OL, Becker JT, Somsak D, Dew MA, DeKosky ST. Awareness of cognitive impairment and anosognosia in probable Alzheimer's disease. Eur Neurol. 1994;34:277-282.
10. Auchus AP, Goldstein FC, Green J, et al. Unawareness of cognitive impairments in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7:25-29.
11. Migliorelli R, Petracca G, Teson A, Sabe L, Leiguarda R, Starkstein SE. Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease. Psychol Med. 1995;25:505-513.
12. Derouesne C, Thibault S, Lagha-Pierucci S, et al. Decreased awareness of cognitive impairment in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry. 1999;14:1019-1030.
13. Kotler-Cope S, Camp CJ. Anosognosia in Alzheimer's disease. Alzheimer Dis Assoc Disord. 1995;9:52-56.
14. Sevush S, Leve N. Denial of memory deficit in Alzheimer's disease. Am J Psychiatry. 1993;150:748-751.
15. Seltzer B, Vaterling JJ, Hale MA, et al. Unawareness of memory deficit in Alzheimer's disease: relation to mood other disease variables. Neuropsychiatry Neuropsychol Behav Neurol. 1995;8:176-181.
16. Reisberg B, Ferris SH, Anand R, et al. Functional staging of dementia of the Alzheimer type. Ann NY Acad Sci. 1984;435:481-483.
17. Green J, Goldstein FC, Sirockman BE, Green RC. Variable awareness of deficits in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1993;3:159-165.
18. Vasterling JJ, Seltzer B, Foss JW, Vanderbrook V. Unawareness of deficit in Alzheimer's disease. Domain-specific differences and disease correlates. Neuropsychiatry Neuropsychol Behav Neurol. 1995;8:26-32.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Wilson B, Cockburn J, Baddeley A, Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J Clin Exp Neuropsychol. 1989;11:855-870.
23. Sunderland A, Harris JE, Baddeley AD. Do laboratory tests predict everuday memory? A neuropsychological study. J Verbal Learning Verbal Behav. 1983;22:341-357.
24. Kazui H, Watamori TS, Honda R, Mori E. The validation of a Japanese version of the Everyday Memory Checklist [in Japanese]. No To Shinkei. 2003;55:317-325.
25. Wechsler DA. WMS-R Manual. New York, NY: Psychological Corporation; 1987.
26. Sugishita M. Manual for the Japanese version of WMS-R. Tokyo, Japan: Nihon Bunka Kagakusha Co, Ltd; 2001.
27. Kertesz A. The Western Aphasia Battery. New York, NY: Grune & Stratton Inc; 1982.
28. Sugishita M. Japanese edition of Western Aphasia Battery. Tokyo, Japan: Igaku-Shoin Ltd; 1986.
29. Sugishita M, Yamazaki K. Japanese Raven's Colored Progressive Matrices. Tokyo, Japan: Nihon Bunka Kagakusha Co, Ltd; 1993.
30. Yoshimura N, Soma Y, Ootsuki M. Relations between neuropsychological findings and lateral asymmetries of cerebral blood flow measured by SPECT in dementia of Alzheimer type [in Japanese]. Rinsho Shinkeigaku. 1993;33:1029-1032.
31. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
32. Hirono N, Mori E, Ikejiri Y, et al. Japanese version of the Neuropsychiatric Inventory: a scoring system for neuropsychiatric disturbance in dementia patients [in Japanese]. No To Shinkei. 1997;49:266-271.
33. Takatuki Y, Hirono N, Yamashita H, et al. Study of language function in Alzheimer patients using Japanese version of Western Aphasia Battery [in Japanese]. Higher Brain Function Research. 1998;18:315-322.
34. Ikeda M, Shigenobu K, Fukuhara R, et al. Delusions of Japanese patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2003;18:527-532.
35. Sevush S. Relationship between denial of memory deficit and dementia severity in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:88-94.
36. DeBettignies BH, Mahurin RK, Pirozzolo FJ. Insight for impairment in independent living skills in Alzheimer's disease and multi-infarct dementia. J Clin Exp Neuropsychol. 1990;12:355-363.
37. Karlawish JH, Casarett D, Klocinski J, Clark CM. The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience. J Am Geriatr Soc. 2001;49:1066-1070.
38. Christensen H, Kopelman MD, Stanhope N, Lorentz L, Owen P. Rates of forgetting in Alzheimer dementia. Neuropsychologia. 1998;36:547-557.
39. Derrer DS, Howieson DB, Mueller EA, Camicioli RM, Sexton G, Kaye JA. Memory testing in dementia: how much is enough? J Geriatr Psychiatry Neurol. 2001;14:1-6.
40. Reed BR, Paller KA, Mungas D. Impaired acquisition and rapid forgetting of patterned visual stimuli in Alzheimer's disease. J Clin Exp Neuropsychol. 1998;20:738-749.
41. Marshall GA, Kaufer DI, Lopez OL, Rao GR, Hamilton RL, DeKosky ST. Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:1396-1400.
42. Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF III. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology. 1991;41:906-912.
43. Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thai LJ. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry. 1992;149:184-189.
44. Starkstein SE, Vazquez S, Petracca G, et al. A SPECT study of delusions in Alzheimer's disease. Neurology. 1994;44:2055-2059.
45. Hirono N, Mori E, Ishii K, et al. Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1998;10:433-439.
46. Sultzer D, Brown C, Mandelkern M, et al. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry. 2003;160:341-349.
47. Fukuhara R, Ikeda M, Nebu A, et al. Alternation of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport. 2001;12:2473-2476.
48. Prigatano GP, Schacter DL. Awareness of Deficits After Brain Injury. New York, NY: Oxford University Press; 1991.
49. Constantinidis J, Richard J, Ajuriaguerra J de. Dementias with senile plaques and neurofibrillary tangles. In: Isaacs AD, Post F, eds. Studies in Geriatric Psychiatry. New York, NY: Wiley; 1978:119-152.
50. Rogers SL, Farlow MR, Doody RS. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 1998;50:136-145.
51. Forette F, Anand R, Gharabawi G. A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon). Eur J Neurol. 1999;6:423-429.
52. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's Disease. Arch Neurol. 1999;56:1388-1393.
53. Rosler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract Suppl. 2002;127:20-36.
54. Daniel DG. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry. 2000;61(suppl 14):49-52.